MB-Buf is a conjugate of methylene blue and bufalin. Upon photoactivation, MB-Buf selectively degrades GPX4. It induces apoptosis, ferroptosis, and the production of reactive oxygen species (apoptosis). MB-Buf has applications in cancer research, such as in the study of breast cancer.
